Investment Analysts’ updated eps estimates for Wednesday, August 14th:
Abeona Therapeutics (NASDAQ:ABEO) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $15.00 price target on the stock.
Acumen Pharmaceuticals (NASDAQ:ABOS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $15.00 price target on the stock.
Allstate (NYSE:ALL) had its buy rating reaffirmed by analysts at Roth Mkm. They currently have a $200.00 target price on the stock.
Aquestive Therapeutics (NASDAQ:AQST) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $9.00 price target on the stock.
Artelo Biosciences (NASDAQ:ARTL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $5.00 price target on the stock.
Atalaya Mining (LON:ATYM) had its hold rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 480 ($6.13) target price on the stock.
Atalaya Mining (LON:ATYM) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 585 ($7.47) target price on the stock.
Atyr PHARMA (NASDAQ:ATYR) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $16.00 target price on the stock.
Boeing (NYSE:BA) had its positive rating reiterated by analysts at Susquehanna. Susquehanna currently has a $230.00 price target on the stock.
Beam Global (NASDAQ:BEEM) had its hold rating reiterated by analysts at Needham & Company LLC.
Beam Global (NASDAQ:BEEM) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $30.00 price target on the stock.
Beeks Financial Cloud Group (LON:BKS) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 260 ($3.32) price target on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $9.00 price target on the stock.
Broadwind (NASDAQ:BWEN) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 price target on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $33.00 price target on the stock.
Cidara Therapeutics (NASDAQ:CDTX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $25.00 target price on the stock.
Cidara Therapeutics (NASDAQ:CDTX) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.
Chipotle Mexican Grill (NYSE:CMG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a $67.00 price target on the stock.
Chipotle Mexican Grill (NYSE:CMG) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $70.00 price target on the stock.
CML Microsystems (LON:CML) had its house stock rating reiterated by analysts at Shore Capital.
Cepton (NASDAQ:CPTN) had its hold rating reaffirmed by analysts at Westpark Capital.
Caribou Biosciences (NASDAQ:CRBU) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.
Cytosorbents (NASDAQ:CTSO) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $1.00 price target on the stock.
CuriosityStream (NASDAQ:CURI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $1.35 price target on the stock.
Daré Bioscience (NASDAQ:DARE) had its hold rating reissued by analysts at Maxim Group.
DraftKings (NASDAQ:DKNG) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $50.00 target price on the stock.
DraftKings (NASDAQ:DKNG) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 target price on the stock.
Digimarc (NASDAQ:DMRC) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $40.00 price target on the stock.
Doximity (NASDAQ:DOCS) had its hold rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $35.00 target price on the stock, up from their previous target price of $31.00.
Electrovaya (NASDAQ:ELVA) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $16.00 target price on the stock.
Enlight Renewable Energy (NASDAQ:ENLT) had its buy rating reissued by analysts at Roth Mkm. The firm currently has a $20.00 price target on the stock.
European Wax Center (NASDAQ:EWCZ) had its outperform rating reiterated by analysts at Telsey Advisory Group. They currently have a $16.00 target price on the stock.
Fate Therapeutics (NASDAQ:FATE) had its hold rating reiterated by analysts at Needham & Company LLC.
Flutter Entertainment (LON:FLTR) had its hold rating reiterated by analysts at Shore Capital.
Flutter Entertainment (NYSE:FLUT) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $255.00 target price on the stock.
FS KKR Capital (NYSE:FSK) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $20.00 target price on the stock.
Gain Therapeutics (NASDAQ:GANX) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. They currently have a $8.00 price target on the stock.
Genuit Group (LON:GEN) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 545 ($6.96) price target on the stock.
Alphabet (NASDAQ:GOOGL) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $210.00 price target on the stock.
Hawaiian Electric Industries (NYSE:HE) had its in-line rating reiterated by analysts at Evercore ISI. The firm currently has a $16.00 target price on the stock.
H&R Block (NYSE:HRB) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $60.00 price target on the stock.
Hut 8 (NASDAQ:HUT) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $17.00 target price on the stock.
Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $15.00 price target on the stock.
IG Group (LON:IGG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 1,065 ($13.60) target price on the stock.
Illumina (NASDAQ:ILMN) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $242.00 target price on the stock.
Intapp (NASDAQ:INTA) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $46.00 target price on the stock.
IO Biotech (NASDAQ:IOBT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $12.00 price target on the stock.
Just Group (LON:JUST) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 110 ($1.40) price target on the stock.
Korro Bio (NASDAQ:KRRO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $100.00 target price on the stock.
Kezar Life Sciences (NASDAQ:KZR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $7.00 target price on the stock.
Lowe’s Companies (NYSE:LOW) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $230.00 target price on the stock.
Intuitive Machines (NASDAQ:LUNR) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $10.00 target price on the stock.
Intuitive Machines (NASDAQ:LUNR) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $10.00 price target on the stock.
Lexeo Therapeutics (NASDAQ:LXEO) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $23.00 price target on the stock.
Macy’s (NYSE:M) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $21.00 target price on the stock.
Main Street Capital (NYSE:MAIN) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $52.00 target price on the stock.
Seres Therapeutics (NASDAQ:MCRB) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $1.25 target price on the stock.
Seres Therapeutics (NASDAQ:MCRB) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $10.00 price target on the stock.
Nkarta (NASDAQ:NKTX) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $13.00 target price on the stock.
NeuroPace (NASDAQ:NPCE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $18.00 target price on the stock.
Ocuphire Pharma (NASDAQ:OCUP) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $18.00 price target on the stock.
ORIC Pharmaceuticals (NASDAQ:ORIC) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $21.00 price target on the stock.
Paltalk (NASDAQ:PALT) had its hold rating reissued by analysts at Maxim Group.
Palo Alto Networks (NASDAQ:PANW) had its hold rating reissued by analysts at Westpark Capital.
Piedmont Office Realty Trust (NYSE:PDM) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $11.00 target price on the stock, up from their previous target price of $10.00.
Privia Health Group (NASDAQ:PRVA) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $28.00 price target on the stock.
Senseonics (NYSE:SENS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $2.00 price target on the stock.
Medicine Man Technologies (OTCMKTS:SHWZ) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $2.50 price target on the stock.
Medicine Man Technologies (OTC:SHWZ) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $2.50 price target on the stock.
Solid Biosciences (NASDAQ:SLDB) had its buy rating reissued by analysts at HC Wainwright. They currently have a $16.00 price target on the stock.
Sportradar Group (NASDAQ:SRAD) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $16.00 price target on the stock.
Sportradar Group (NASDAQ:SRAD) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $16.00 price target on the stock.
Sportradar Group (NASDAQ:SRAD) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $12.00 price target on the stock.
Secure Trust Bank (LON:STB) had its house stock rating reiterated by analysts at Shore Capital.
Stagwell (NASDAQ:STGW) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $8.50 target price on the stock.
Sutro Biopharma (NASDAQ:STRO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $12.00 target price on the stock.
Tenon Medical (NASDAQ:TNON) had its speculative buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $3.00 price target on the stock.
Toll Brothers (NYSE:TOL) had its neutral rating reiterated by analysts at Wedbush. The firm currently has a $120.00 price target on the stock.
Entrada Therapeutics (NASDAQ:TRDA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.
Tesla (NASDAQ:TSLA) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $215.00 target price on the stock.
Taiwan Semiconductor Manufacturing (NYSE:TSM) had its positive rating reaffirmed by analysts at Susquehanna. They currently have a $250.00 price target on the stock.
Uranium Energy (NYSEAMERICAN:UEC) had its buy rating reiterated by analysts at Roth Mkm. Roth Mkm currently has a $9.00 target price on the stock.
Uranium Energy (NYSEAMERICAN:UEC) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $10.25 price target on the stock.
Ultimate Products (LON:ULTP) had its house stock rating reiterated by analysts at Shore Capital.
Ultimate Products (LON:ULTP) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 182 ($2.32) target price on the stock.
Urban Outfitters (NASDAQ:URBN) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $49.00 price target on the stock.
UroGen Pharma (NASDAQ:URGN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $60.00 price target on the stock.
Vigil Neuroscience (NASDAQ:VIGL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $17.00 target price on the stock.
Yatra Online (NASDAQ:YTRA) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its overweight rating reissued by analysts at Cantor Fitzgerald.
Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
